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ABSTRACT

Isoform 2 of calsequestrin (CSQ2) is the main calciumbinding protein of the sarcoplasmic reticulum (SR) and is expressed in both cardiac and skeletal muscle. CSQ2 acts as an SR calcium (Ca
2+ ) sensor and regulates SR Ca 2+ release via interactions with triadin, junctin, and the ryanodine receptor. Various mutations of the csq2 gene lead to altered Ca 2+ release and contractile dysfunction and contribute to the development of arrhythmias and sudden cardiac death in young individuals aff ected by CPVT . Transgenic mice carrying one of the identifi ed CSQ2 point mutations (R33Q) associated with CPVT were developed, and a drastic reduction in the mutated protein was observed. Following a biomolecular approach, several analyses were performed using diff erent antibody treatments to identify when the reduction of CSQ2 begins, to unveil the mechanism involved in the reduction of CSQ2 and to verify whether other proteins are aff ected by the presence of the mutated protein. Th e results of this study showed that mutated CSQ2 levels decreased soon after birth, in conjunction with decreased levels of other important junctional SR proteins, including triadin (TD). Th e up-regulation of proteins associated with the unfolded protein response (UPR) was also observed, and the ATF6-dependent pathway was activated by the UPR. Th e presence of the R33Q mutation induced the decrease of CSQ2 via UPR activation and subsequent proteasomal degradation.
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SAŽETAK
Izoforma 2 kalsekvestrina (CSQ2) je glavni kalcijum-vezujući protein sarkoplazmatskog retikuluma (SR) i nalazi
INTRODUCTION
Sudden cardiac death causes approximately 300,000 deaths each year in Europe and the U.S.A.; ventricular fibrillation is the underlying mechanism of most diseases that lead to sudden cardiac death. The identification of mechanisms causing life-threatening arrhythmias is a major priority in the biomedical field (1, 2) . Given the crucial role of Ca 2+ in the generation of focal arrhythmias, the mechanisms responsible for Ca 2+ homeostasis in the SR of cardiomyocytes are of great importance in cardiac pathophysiology. The discovery of SR proteins, such as ryanodine receptor (RyR) and CSQ, that play key roles in the mechanisms behindunderlying inherited arrhythmia syndromes such as CPVT emphasises the link between changes in intracellular Ca 2+ homeostasis and arrhythmogenesis (3, 4) . CPVT occurs at a young age as a result of exercise or emotional stress, is characterised by recurrent syncope, convulsions, and cardiovascular collapse and can lead to sudden death (4) . Homozygous CSQ2 mutations (5) explain 3% of all CPVT cases, while approximately 50% of patients have mutations in RyR2 (6). Song and colleagues (7) have demonstrated the existence of common pathophysiological mechanisms caused by alterations in RyR2 and/or CSQ2 that relate to CPVT.
To close the gap between experimental and clinical data, it is extremely important to develop experimental animal models that phenotypically copy the clinical disease. This "challenge" is particularly demanding in arrhythmogenic diseases because of the large differences between humans and mice in ion channel profiles and action potential durations. CPVT has proven to be an exception in comparison with other hereditary diseases, represented by transgenic mice that have a low level of analogy with the phenotype of human patients . Knock-in (KI) RyR2-R4497 (8) and CASQ2-R33Q (9) mouse models currently exist as autosomal dominant and recessive CPVT models, respectively. The delicate balance that regulates the flow of calcium through the membrane of the SR in cardiomyocytes and, consequently, the balance between cytoplasmic and extracellular Ca 2+ play critical roles in ensuring cell viability, preserving normal contractile function and providing heart rate stability. The SR, an important cell organelle, and the two SR proteins RyR and CSQ play crucial roles in these processes. In fact, the mechanism associated with depolarisation of the muscle fibre plasma membrane followed by release of Ca 2+ from the SR, called coupling excitation-contraction (EC), depends on the plasma membrane calcium channel L type receptor dihydropyridine (DHPR) and the RyR receptor present on the membrane of SR terminal cisternae; both are Ca 2+ release units (CRUs) (10). Calsequestrin is the major Ca
2+
-binding protein present in the junctional SR of skeletal and cardiac muscle fibres. In mammals, there are two CSQ isoforms encoded by different genes: the skeletal isoform CSQ1 is expressed in fast-and slow-twitch skeletal muscle, while the cardiac isoform CSQ2 is expressed in both cardiac and skeletal muscle. Some CSQ2 mutations seem to affect protein synthesis, leading to the reduction or absence of CSQ2 in the heart (9), while other mutations seem to induce the expression of defective proteins, which show altered abilities to bind Ca 2+ and/or to perform their proper function (9) . All experimental evidence has implicated mechanisms of posttranscriptional regulation. Among the possible mechanisms involved in this regulation is endoplasmic reticulum (ER)-associated protein degradation (ERAD), which is responsible for the degradation of proteins synthesised at the ER lumen via the proteasome following activation of an ER stress response pathway.
Various factors can activate an ER stress response pathway. One such factor, the presence of incorrectly folded proteins, activates the unfolded protein response (UPR). To reach a possible explanation for the drastic reduction of CSQ2-R33Q in 8-week-old adult mice (9), the first objective was to determine at what age the CASQ2 reduction began. The other objectives were to determine whether any other proteins were affected by the reduced levels of CSQ2 and to reveal the mechanisms involved in the reduction of CSQ2-R33Q.
MATERIALS AND METHODS
Molecular analyses were performed on total heart homogenates of 4 wt/wt and 4 knock-in CSQ2-R33Q/R33Q mice, respectively. All experimental protocols were approved by the Institutional Ethical Committees of the Universities of Padova and Chieti. Mice were kept in accredited animal facilities and sacrificed by anaesthetic euthanasia. Four hearts were used for each genotype, and only male mice were selected for the analyses. The samples were homogenised, and the corresponding proteins were quantified using the Lowry biochemical method.
Western Blotting was used for protein level determination. For each sample, 15-50 μg of protein was loaded onto 7.5-10% SDS-polyacrylamide gels, depending on the protein being investigated. The following dilutions and primary antibodies were used: polyclonal anti-CASQ1/CASQ2 (1:1,000), monoclonal anti-TR (1:1,000), polyclonal antiBiP (GRP78) (1:500), and polyclonal anti-CRT (1:1000), all from Affinity Bioreagents (Affinity Bioreagents, Golden, CO); polyclonal anti-GRP94 (1:1,000) from Santa Cruz (Santa Cruz Biotechnology, Santa Cruz, CA); and monoclonal anti-ATF6 from Thermo Scientific (Thermo Fisher Scientific Inc., Waltham, MA). Secondary anti-mouse or anti-rabbit (1:5,000) alkaline phosphatase-conjugated antibodies were from Sigma (Milan, Italy). After electroblotting on nitrocellulose paper, the equivalence and homogeneity of the loaded samples were verified by staining the nitrocellulose membrane with Ponceau Red. The immunodecorated bands were visualised with a ready-to-use precipitating substrate system for alkaline phosphatase (BCIP/ NBT liquid substrate system; Sigma). Images were obtained with an HP Scanjet scanner and Adobe Photoshop CS2, version 9.0. Densitometry was performed with Scion Image Software without modification of the images (raw images) to quantify protein band intensities.
Data are expressed as the means ± SE. Statistical analyses were performed using Origin 8.5 software. Student's ttest was used for comparisons between data from wt/wt and knock-in CSQ2-R33Q/R33Q mice. Statistical significance was set at P< 0.05.
RESULTS
Western blot data showed that the amount of mutated protein was reduced early after birth, with a drastic reduction at 6 days ( Figure 1 ). Subsequently, increased protein levels were observed at 9 days and 2 weeks. After 2 weeks, decreased levels of CSQ2-R33Q were observed, and protein levels reached a minimum at 8 weeks. Thus, the lowest levels of CSQ2-R33Q expression were observed at 6 days and 8 weeks (20% of the CSQ2 in wt/wt mice).
Triadin levels were also reduced in 8-week-old knockin CSQ2-R33Q/R33Q mice. TD32 is the main cardiac isoform of triadin and is one of the proteins that anchor CSQ2 in proximity to RyR2. In control hearts, the TD32 content increased markedly and quickly after birth (Figure 2A) . After 6 days, TD32 expression levels were 5-fold higher than those in 2-day-old wt/wt mice. However, after 6 days, TD32 levels began to quickly decrease in wt/wt mice. In knock-in mouse hearts, TD32 showed a different expression pattern, increasing slowly over time ( Figure 2B ). When TD32 levels in knock-in hearts were compared with controls at different ages, a drastic reduction in the protein levels early after birth (~50%) was observed, and this reduction remained constant at all ages ( Figure 3) . This research was also directed towards the molecular analysis of 3 unfolded protein response (UPR) proximal effectors. The protein expression of one of these proximal effectors, transcriptional factor activating transcription factor 6 (ATF6), was analysed in different age groups of wt/wt and knock-in CSQ2-R33Q/R33Q mice. These analyses showed the presence of increased levels of the active form of ATF6 in 2-week-old knock-in CSQ2-R33Q/R33Q mice ( Figure 4) . The transcriptional activation of UPR target genes, including those that function as part of the ER protein-folding machinery (ER chaperones) such as calreticulin (CRT), glucose-regulate protein-78 (GRP78) and glucose-regulate protein-94 (GRP94), was also analysed. The results showed that all three analysed ER chaperones were up-regulated, with peak expression levels observed in the hearts of 2-week-old knock-in CSQ2-R33Q/R33Q mice ( Figure 5 ). For example, GRP78 levels were five times higher in 2-week-old knock-in CSQ2-R33Q/R33Q mice than in wt/wt mice ( Figure 5B ). Unlike GRP78, GRP94 protein levels remained high in knock-in CSQ2-R33Q/R33Q mice even after 2 weeks ( Figure 5C ).
DISCUSSION
Calsequestrin is an acid glycoprotein with a moderate affinity (Kd = 1 mM) and high ability for bindingto Ca 2+ ; it brings the total amount of Ca 2+ within the SR to 20 mM and maintains the concentration of free Ca 2+ at 1 mM (11) . CSQ has a greater ability to bind Ca 2+ in its polymeric form in the presence of 1 mM Ca 2+ . The C-terminus of CSQ contains the highest density of amino acids and is forced to form a Ca 2+ -binding pocket in polymeric form (12) . CSQ plays an important role as a Ca 2+ buffer and regulates the activities of RyR in relation to the Ca 2+ concentration in the SR lumen (13) . Furthermore, CSQ, together with triadin and junctin, was proposed to play an important role in SR junction development (14) . As proposed by Beard (11) , CSQ may also act as a chaperone through its kinase activity to ensure the correct folding of proteins present in the SR lumen and most likely plays an important role in removing toxic substances from the SR WT and knock-in CSQ2-R33Q/R33Q blots incubated with monoclonal anti-ATF6 antibody, which binds the full-length and active/ cleaved forms of ATF6. Heart proteins from 2 day-, 9 day-and 2 week-old mice were used in these experiments.
lumen. CSQ is present in the lumen of the SR terminal cisternae as a linear polymer and is anchored to RyR via two transmembrane proteins, triadin and junctin, forming the Ca2+ release channel complex (11) .
Presently, 8 recessive mutations in the csq2 gene have been linked to CPVT. Four of them are non-sense mutations that generate premature stop codons, while the other four are point mutations (15) (16) (17) . The unique characteristic of each mutation can alter the clinical phenotype of the disease (18) . In these analyses, we chose specific criteria to obtain complete information regarding postnatal development; thus, we have a detailed picture of the events triggered by the presence of the CSQ2 R33Q point mutation. The first age used was as close to birth as possible (2 days); then, 1 week after birth was used. Nine-day-old mice were chosen for molecular analysis because this age represented an intermediate time point between the first and second weeks. Two weeks after birth was considered a critical time point for the cardiomyocyte based on the results of previous studies (10) that showed the appearance of optimal morphological cardiomyocyte characteristics at this point, which were responsible for the correct functioning of the heart muscle in adulthood. Finally, as reported by Flucher and FranziniArmstrong, 8 weeks was considered a good point to analyse adult hearts (10) . The mutated protein levels were analysed first, using the wild-type protein levels as a control. CSQ2-R33Q is CSQ2 with a mutated amino acid in position 33; this mutation did not seem to affect the secondary or tertiary conformation of the overall protein (29). The CSQ2 mutation knock-in mouse (9) was characterised in vitro and in vivo and was demonstrated to be an identical copy of the patient phenotype. CSQ2 and triadin protein levels were reduced, while the corresponding mRNAs levels remained unchanged (9) . The CSQ2-R33Q protein levels found in this study confirmed the results of Rizzi and colleagues (9) , who reported that CSQ2-R33Q proteins levels were significantly lower than wild-type protein levels. Comparison of the results reported in Figures 2A and 2B suggested that TD32 levels decreased due to the lack of functional CSQ2 from birth in the CSQ2-R33Q/R33Q mice. Results from a previous study (19) also showed that CSQ2 protein levels were significantly reduced in adult Trdn -/-mice. The mechanism of the post-transcriptional control of unfolded proteins can explain the reduction of CSQ2-R33Q protein levels without any effect on mRNA content. ER stress is defined as an imbalance between the load of unfolded proteins that enter the ER and the capacity of the cellular machinery to handle this load; ER stress results in a series of different responses. In eukaryotic cells, the majority of secreted and trans-membrane proteins are synthesised and matured in the ER lumen. Proteins enter the ER as unfolded polypeptide chains. The incorrect folding of nascent proteins may occur in response to many environmental stresses or as a result of mutations that disrupt the protein structure. An imbalance between the load of unfolded proteins entering the ER and the ability of the cell machinery to handle this load is defined as ER stress, which triggers a series of responses known as the UPR (20) . When ER stress occurs, three ER transmembrane sensors are activated to initiate adaptive responses. These sensors include protein kinase-like ER kinase (PERK), inositol-requiring kinase 1 (IRE1), and ATF6. The N-termini of these transmembrane UPR sensors are located inside of the ER lumen and the Ctermini are within the cytosol, thereby connecting the ER lumen to the cytosol. All three sensors are maintained in an inactive state through the interaction of their N-termini with GRP78. When unfolded proteins accumulate in the ER, GRP78 releases these sensors, allowing for their oligomerisation and initiation of the UPR. Under these conditions, GRP78 translocates into the ER lumen, binds proteins and facilitates their folding. At the same time, IRE-1, ATF6, and PERK are activated and induce the transcription of ER stress response genes (21) . To analyse the signal transduction cascade involving PERK, attention has focused on the expression of ribosomal protein eIF2α, a translation initiation factor. Phosphorylation of eIF2α by PERK leads to the decrease of most mRNA translation (22) . This first response to ER stress reduces the load of proteins that must enter the ER. This is a transient form of adaptation that is realised by slowing the synthesis and translocation of protein into the ER lumen. Preliminary results have shown an up-regulation of phosphorylated eIF2α expression in 2-week old knock-in CS2R33Q/R33Q mice. The inactive form, eIF2α-P, lowers the levels of newly synthesised proteins. Subsequently, the capacity of the ER to handle unfolded proteins is increased, representing a more long-term adaptation that entails transcriptional activation of UPR target genes, including those that function as ER chaperones such as CRT, GRP78 and GRP94.
The activated form of ATF6 plays an important role in the synthesis of chaperones such as GRP78 and CRT (23) . This was confirmed by experimental data showing that in 2-week-old mice, increased ATF6 levels corresponded to the highest, statistically significant expression levels of GRP78 ( Figure 5B ) and CRT ( Figure 5A) . Results in the literature show that ERAD is activated if it is not possible to restore the balance. ERAD provides 1) the recognition of incorrectly folded proteins, 2) translocation of such proteins into the cytoplasm, where they are bound to numerous ubiquitin molecules and 3) degradation via the proteasome (24) . GRP94 is thought to play an important role in the response to incorrectly folded proteins, participating in their translocation from the ER lumen to the cytosol (25) . Unlike GRP78, GRP94 protein levels remained high in knock-in CSQ2-R33Q/R33Q mice even after 2 weeks (Figure 5C) . This indicated the possible activation of ERAD. Therefore, in accordance with these experimental data, it was speculated that the R33Q mutation induced structural and/or functional changes to CSQ2 that led to UPR activation and subsequent CSQ2 degradation. Thus, the reduction of CSQ2-R33Q might be due to its degradation via ERAD. Proteins with serious folding errors and protein aggregates are degraded by autophagy. In fact, many of the components that mediate autophagy are UPR target genes (26) . If ER stress is permanent and irreparable, the process of apoptosis is activated and leads to cell death (27) . Thus, it is of extreme interest to extend analyses to markers of autophagy and apoptosis such as CHOP, an ER stress-associated proapoptotic transcription factor (28) .
CONCLUSIONS
These study results showed that mutated CSQ2 levels decreased soon after birth in conjunction with the decreased levels of other important junctional SR proteins such as TD. The up-regulation of proteins associated with the UPR was also observed; this led to ATF6-dependent pathway activation by the UPR. The R33Q mutation induced the decrease of CSQ2 levels through UPR activation and subsequent proteasomal degradation. Further studies are necessary to confirm these results.
